General Announcement::Update on listing of equity shares of Glenmark Life Sciences Limited

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
06-Aug-2021 16:18:36
Status
New
Announcement Sub Title
Update on listing of equity shares of Glenmark Life Sciences Limited
Announcement Reference
SG210806OTHRRXW1
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary and Compliance Officer
Effective Date and Time of the event
06/08/2021 00:00:00
Description (Please provide a detailed description of the event in the box below)
This is further to our intimations dated April 16, 2021, July 20, 2021 and August 3, 2021, on the subject mentioned above, we would like to inform you that the equity shares of the wholly owned subsidiary of the Company, Glenmark Life Sciences Limited, were admitted for listing by BSE Limited and National Stock Exchange of India Limited with effect from August 6, 2021.

Attachments

SGX GLS Listing Intimation.pdf
Total size =269K